MAP2K7 and melanoma: To test whether the prolonged survival of mice treated with digitoxin plus MEK inhibitor required inhibition of ATP1A1 we over-expressed mouse Atp1a1 in M481 melanoma cells (which is insensitive to therapeutic doses of cardiac glycosides; Supplementary Fig. 5).